← Back to headlines
Non-Pharma Firms Poised to Benefit from GLP-1 Trend
Several non-pharmaceutical companies are identified as potential beneficiaries of the growing GLP-1 drug trend, indicating a broader economic impact beyond the pharmaceutical sector.
20 Jun, 12:45 — 20 Jun, 12:45
Sources
Showing 1 of 1 sources
